CASP3 and breast cancer: Similar findings were obtained by Soriano et al. [36], who demonstrated that the supplementation with molecular iodine or potassium iodide increases PPARγ and caspase-3 expression and thus triggers caspase-mediated apoptosis pathways in mammary cancer.